134 related articles for article (PubMed ID: 15242870)
21. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
[TBL] [Abstract][Full Text] [Related]
22. Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types.
Lohsen S; Majumder P; Scharer CD; Barwick BG; Austin JW; Zinzow-Kramer WM; Boss JM
Genes Immun; 2014 Dec; 15(8):543-55. PubMed ID: 25101797
[TBL] [Abstract][Full Text] [Related]
23. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes.
Ghosh N; Piskurich JF; Wright G; Hassani K; Ting JP; Wright KL
J Biol Chem; 1999 Nov; 274(45):32342-50. PubMed ID: 10542275
[TBL] [Abstract][Full Text] [Related]
24. Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression.
Smith EM; Gisler R; Sigvardsson M
J Immunol; 2002 Jul; 169(1):261-70. PubMed ID: 12077253
[TBL] [Abstract][Full Text] [Related]
25. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
Rahat MA; Chernichovski I; Lahat N
Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
[TBL] [Abstract][Full Text] [Related]
26. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
27. IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.
Cai Q; Banerjee S; Cervini A; Lu J; Hislop AD; Dzeng R; Robertson ES
PLoS Pathog; 2013 Oct; 9(10):e1003751. PubMed ID: 24204280
[TBL] [Abstract][Full Text] [Related]
28. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
Xi H; Goodwin B; Shepherd AT; Blanck G
Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
[TBL] [Abstract][Full Text] [Related]
29. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
30. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line.
Wong AW; Ghosh N; McKinnon KP; Reed W; Piskurich JF; Wright KL; Ting JP
J Immunol; 2002 Sep; 169(6):3112-9. PubMed ID: 12218128
[TBL] [Abstract][Full Text] [Related]
31. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
32. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
[TBL] [Abstract][Full Text] [Related]
34. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
35. Isolation of a B-cell-specific promoter for the human class II transactivator.
Lennon AM; Ottone C; Rigaud G; Deaven LL; Longmire J; Fellous M; Bono R; Alcaïde-Loridan C
Immunogenetics; 1997; 45(4):266-73. PubMed ID: 9002447
[TBL] [Abstract][Full Text] [Related]
36. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
[TBL] [Abstract][Full Text] [Related]
37. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
38. Identification of CIITA regulated genetic module dedicated for antigen presentation.
Krawczyk M; Seguín-Estévez Q; Leimgruber E; Sperisen P; Schmid C; Bucher P; Reith W
PLoS Genet; 2008 Apr; 4(4):e1000058. PubMed ID: 18437201
[TBL] [Abstract][Full Text] [Related]
39. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
[TBL] [Abstract][Full Text] [Related]
40. Regulation of MHC class II expression in human T-cell malignancies.
Holling TM; Schooten E; Langerak AW; van den Elsen PJ
Blood; 2004 Feb; 103(4):1438-44. PubMed ID: 14563641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]